Cargando…
RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo
OBJECTIVE: To prepare arginine-glycine-aspartate (RGD)-targeted ultrasound contrast microbubbles (MBs) and explore the feasibility of their use in assessing dynamic changes in αvβ3 integrin expression in a murine model of tumor angiogenesis. METHODS: RGD peptides were conjugated to the surfaces of m...
Autores principales: | Hu, Qiao, Wang, Xiao-Yan, Kang, Li-Ke, Wei, Hai-Ming, Xu, Chun-Mei, Wang, Tao, Wen, Zong-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749330/ https://www.ncbi.nlm.nih.gov/pubmed/26862757 http://dx.doi.org/10.1371/journal.pone.0149075 |
Ejemplares similares
-
Promotion of angiogenesis by M13 phage and RGD peptide in vitro and in vivo
por: Safari, Zohreh, et al.
Publicado: (2019) -
Sonophore labeled RGD: a targeted contrast agent for optoacoustic imaging
por: Haedicke, Katja, et al.
Publicado: (2017) -
RGD-Peptide Functionalization
Affects the In Vivo Diffusion of a Responsive Trimeric
MRI Contrast
Agent through Interactions with Integrins
por: Gambino, Giuseppe, et al.
Publicado: (2021) -
Noninvasive and Quantitative Assessment of In Vivo Fetomaternal Interface Angiogenesis Using RGD-Based Fluorescence
por: Keramidas, M., et al.
Publicado: (2014) -
Dual-Mode Contrast Agents with RGD-Modified Polymer for Tumour-Targeted US/NIRF Imaging
por: Nie, Zhenhui, et al.
Publicado: (2020)